SARS-CoV-2 infection risk assessment from σCOVID19
Risk probability | Target/assessment | SARS-CoV-2 | Volunteer A | Volunteer B | Volunteer C | Volunteer D | Volunteer E | Volunteer F | Volunteer G | NTC |
---|---|---|---|---|---|---|---|---|---|---|
Pharyngeal, Trizol-manual | RdRP2 | 0.998 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 |
E2 | 0.998 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
S2 | 0.998 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
N1 | 0.998 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Assessment | Positive | Negative | Negative | Negative | Negative | Negative | Negative | Negative | ||
Pharyngeal, Trizol-Kit | RdRP2 | 0.998 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | - | 0.000 |
E2 | 0.998 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | - | 0.000 | |
S2 | 0.998 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | - | 0.000 | |
N1 | 0.998 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | - | 0.000 | |
Assessment | Positive | Negative | Negative | Negative | Negative | Negative | Negative | |||
Saliva, Trizol-Kit, 2-step qRT-PCR | RdRP2 | 0.998 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 |
E2 | 0.998 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
S2 | 0.998 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
N1 | 0.998 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Assessment | Positive | Negative | Negative | Negative | Negative | Negative | Negative | Negative | ||
Saliva, Trizol-Kit, 1-step qRT-PCR | RdRP2 | 0.998 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 |
E2 | 0.998 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
S2 | 0.998 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
N1 | 0.998 | 0.000 | 0.034 | 0.000 | 0.001 | 0.000 | 0.000 | 0.000 | 0.000 | |
Assessment | Positive | Negative | Negative | Negative | Negative | Negative | Negative | Negative |